Literature DB >> 12210861

Genetic and clinical heterogeneity in paroxysmal kinesigenic dyskinesia: evidence for a third EKD gene.

Sian D Spacey1, Enza-Maria Valente, Gurusidheshwar M Wali, Thomas T Warner, Paul R Jarman, Anthony H V Schapira, Peter H Dixon, Mary B Davis, Kailash P Bhatia, Nicholas W Wood.   

Abstract

Paroxysmal kinesigenic dyskinesia (PKD) is characterised by paroxysms of choreic, dystonic, ballistic, or athetoid movements. The attacks typically last seconds to minutes in duration and are induced by sudden voluntary movement. PKD loci have been identified on chromosome 16. We present the clinical and genetic details of two British and an Indian family with PKD. Linkage to the PKD loci on chromosome 16 has been excluded in one of these families, providing evidence for a third loci for PKD. Detailed clinical descriptions highlight the presence of both adolescent and infantile seizures in some of the PKD families. This study attempts to clarify the relationship of adolescent and infantile seizures to PKD and provides evidence that PKD is both genetically and clinically heterogeneous. Copyright 2002 Movement Disorder Society

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12210861     DOI: 10.1002/mds.10126

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  15 in total

1.  Diagnosis and treatment of paroxysmal dyskinesias revisited.

Authors:  Iris Unterberger; Eugen Trinka
Journal:  Ther Adv Neurol Disord       Date:  2008-09       Impact factor: 6.570

2.  Clinical analysis of nine cases of paroxysmal exercise-induced dystonia.

Authors:  Guoping Peng; Kang Wang; Yuan Yuan; Xuning Zheng; Benyan Luo
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-12-28

3.  Localization and mutation detection for paroxysmal kinesigenic choreoathetosis.

Authors:  Te Du; Bin Feng; Xin Wang; Wei Mao; Xilin Zhu; Liping Li; Bei Sun; Nifang Niu; Yang Liu; Yuping Wang; Biao Chen; Xingqiu Cai; Ying Liu
Journal:  J Mol Neurosci       Date:  2007-10-19       Impact factor: 3.444

Review 4.  Episodic movement disorders: from phenotype to genotype and back.

Authors:  Knut Brockmann
Journal:  Curr Neurol Neurosci Rep       Date:  2013-10       Impact factor: 5.081

Review 5.  The genetics of dystonias.

Authors:  Mark S LeDoux
Journal:  Adv Genet       Date:  2012       Impact factor: 1.944

6.  Paroxysmal dyskinesias.

Authors:  Shyamal H Mehta; John C Morgan; Kapil D Sethi
Journal:  Curr Treat Options Neurol       Date:  2009-05       Impact factor: 3.598

7.  Identification of PRRT2 as the causative gene of paroxysmal kinesigenic dyskinesias.

Authors:  Jun-Ling Wang; Li Cao; Xun-Hua Li; Zheng-Mao Hu; Jia-Da Li; Jian-Guo Zhang; Yu Liang; Nan Li; Su-Qin Chen; Ji-Feng Guo; Hong Jiang; Lu Shen; Lan Zheng; Xiao Mao; Wei-Qian Yan; Ying Zhou; Yu-Ting Shi; San-Xi Ai; Mei-Zhi Dai; Peng Zhang; Kun Xia; Sheng-Di Chen; Bei-Sha Tang
Journal:  Brain       Date:  2011-11-26       Impact factor: 13.501

8.  PRRT2 gene mutations: from paroxysmal dyskinesia to episodic ataxia and hemiplegic migraine.

Authors:  Alice R Gardiner; Kailash P Bhatia; Maria Stamelou; Russell C Dale; Manju A Kurian; Susanne A Schneider; G M Wali; Tim Counihan; Anthony H Schapira; Sian D Spacey; Enza-Maria Valente; Laura Silveira-Moriyama; Hélio A G Teive; Salmo Raskin; Josemir W Sander; Andrew Lees; Tom Warner; Dimitri M Kullmann; Nicholas W Wood; Michael Hanna; Henry Houlden
Journal:  Neurology       Date:  2012-10-17       Impact factor: 9.910

9.  Migraine with aura as the predominant phenotype in a family with a PRRT2 mutation.

Authors:  Una-Marie Sheerin; Maria Stamelou; Gavin Charlesworth; Tamara Shiner; Sian Spacey; Enza-Maria Valente; Nicholas W Wood; Kailash P Bhatia
Journal:  J Neurol       Date:  2012-11-24       Impact factor: 4.849

10.  Novel PRRT2 mutation in an African-American family with paroxysmal kinesigenic dyskinesia.

Authors:  Peter Hedera; Jianfeng Xiao; Andreas Puschmann; Dragana Momčilović; Steve W Wu; Mark S LeDoux
Journal:  BMC Neurol       Date:  2012-09-18       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.